Clinical Trials · NCT04194125
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- University of Warmia and Mazury
- Enrollment
- 25
- Start date
- Feb 2019
- Locations
- 1 site, Poland
- Primary endpoint
- PFS - Progression Free Survival